← FDA DRUG APPROVALS

FDA ANDA · ANDA040550

OXYCODONE AND ACETAMINOPHEN

Sponsor: MALLINCKRODT

APPLICATION
ANDA040550
TYPE
ANDA
ORIGINAL APPROVAL
2004-06-30
LATEST ACTION
2004-06-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

OXYCODONE AND ACETAMINOPHENDiscontinued
ACETAMINOPHEN 500MG, OXYCODONE HYDROCHLORIDE 7.5MG · TABLET · ORAL
OXYCODONE AND ACETAMINOPHENDiscontinued
ACETAMINOPHEN 650MG, OXYCODONE HYDROCHLORIDE 10MG · TABLET · ORAL

Approval history

2004-06-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →